VERA DEMARCHI AIELLO
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina
57 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 57
- Morphologic and immunohistochemical features of pulmonary vasculopathy in end-stage left ventricular systolic failure(2018) CAMPOS, Pompeu Tome Ribeiro de; LOPES, Antonio Augusto; ISSA, Victor Sali; AIELLO, Vera Demarchi
- Caso 1/2017 – Insuficiência Cardíaca Rapidamente Progressiva em Homem de 26 Anos(2017) MARQUES, Lais Costa; PAULA, Rogerio Silva de; CAMILO, Ivna Lobo; AIELLO, Vera Demarchi
- Case 4/2019-26-Year-Old Man with Congenital Chagas Disease and Heart Transplantation(2019) PINESI, Henrique Trombini; STRABELLI, Tania Mara Varejao; AIELLO, Vera Demarchi
- Case 02/2015-A 67 Year-Old Woman with Sudden Cardiogenic Shock in the 7th Day after Acute Myocardial Infarction(2015) PINHEIRO, Bruno Aguiar; YAMADA, Alice Tatsuko; AIELLO, Vera Demarchi
- A ecocardiografia no laboratorio cardiovascular: um guia para a pesquisa com animais(2014) ABDUCH, Maria Cristina Donadio; ASSAD, Renato Samy; MATHIAS JR, Wilson; AIELLO, Vera DemarchiThe feasibility and potential for the morphological and hemodynamic investigation of the heart has been increasing the use of the echocardiography in the research setting. Additionally, the development of new technologies, like the real time 3D echocardiography and speckle tracking, demands validation throughout experimental studies before being instituted in the clinical setting. This paper aims to provide information concerning the particularities of the echocardiographic examination in quadruped mammals, targeting the experimental research.
- Has the Natural History of Primary Heart Tumors in Children Been Modified Recently?(2024) AIELLO, Vera Demarchi
- Superior caval vein syndrome and cardiac inflammatory myofibroblastic tumour in an infant(2023) SOARES, Bernardo Mussi; SOARES, Andressa Mussi; AIELLO, Vera DemarchiThe inflammatory myofibroblastic tumour, although very rare, must be considered in the differential diagnosis of intracardiac masses in children as it has systemic implications. We present a case of an infant whose diagnosis was suspected on clinical basis and echocardiogram, but the anatomopathological analysis with immunohistochemical study was essential for the conclusion of the histological type and orientation of the clinical follow-up.
- Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2-Nomenclature of complications associated with interventional cardiology)(2011) BERGERSEN, Lisa; GIROUD, Jorge Manuel; JACOBS, Jeffrey Phillip; FRANKLIN, Rodney Cyril George; BELAND, Marie Josee; KROGMANN, Otto Nils; AIELLO, Vera Demarchi; COLAN, Steven D.; ELLIOTT, Martin J.; GAYNOR, J. William; KUROSAWA, Hiromi; MARUSZEWSKI, Bohdan; STELLIN, Giovanni; TCHERVENKOV, Christo I.; III, Henry Lane Walters; WEINBERG, Paul; EVERETT, Allen DaleInterventional cardiology for paediatric and congenital cardiac disease is a relatively young and rapidly evolving field. As the profession begins to establish multi-institutional databases, a universal system of nomenclature is necessary for the field of interventional cardiology for paediatric and congenital cardiac disease. The purpose of this paper is to present the results of the efforts of The International Society for Nomenclature of Paediatric and Congenital Heart Disease to establish a system of nomenclature for cardiovascular catheterisation for congenital and paediatric cardiac disease, focusing both on procedural nomenclature and the nomenclature of complications associated with interventional cardiology. This system of nomenclature for cardiovascular catheterisation for congenital and paediatric cardiac disease is a component of The International Paediatric and Congenital Cardiac Code. This manuscript is the second part of the two-part series. Part 1 covered the procedural nomenclature associated with interventional cardiology as treatment for paediatric and congenital cardiac disease. Part 2 will cover the nomenclature of complications associated with interventional cardiology as treatment for paediatric and congenital cardiac disease.
conferenceObject RESTRICTIVE AND HYPERTROPHIC CARDIOMYOPATHIES AS INDICATION FOR HEART TRANSPLANTATION: CLINICAL OUTCOME IN A SINGLE CENTER(2013) TANAKA, Ana Cristina; MIURA, Nana; THOMAZ, Ana Maria; AIELLO, Vera Demarchi; BENEVENUTI, Luiz; TAVARES, Glaucia; NOMURA, Cesar; JATENE, Marcelo Biscegli; AZEKA, EstelaPURPOSE: The purpose of this study was evaluate the prevalence and outcome of restrictive and hypertrophic cardiomyopathies in a cohort of pediatric heart transplantation. METHOD: To evaluate the prevalence and clinical outcome of children with restrictive and hypertrophic cardiomyopathies submitted heart transplantation. RESULTS: From october 1992 to 2012, 115 patients were submitted heart transplantation. 120 transplants were performed at Heart Institute (InCor) University São Paulo Medical School. Seventeen (14,7%) of these patients hat restrictive cardiomyopathy/hypertrophic cardiomyopathy and have undergone to heart transplantation. The mean age was 10,4 years. Survival was 76,4%. Follow-up period ranged from 26 days to 6,6 years. CONCLUSION: Restrictive and hypertrophic cardiomyopathies can be an indication for heart transplantation a favorable outcome.- Caso 2 – Morte Súbita após Cirurgia de Revascularização Miocárdica em Paciente de 49 Anos, Feminina, Diabética, Dislipidêmica, Hipertensa, Obesa(2013) MIRANDA, George Barreto; AIELLO, Vera Demarchi